Antibodies to integrin AVB6 and use of same to treat cancer
US9493566B2 · kind B2 · utility
9Cited by
6References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2013 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Jun 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides antibodies that specifically bind to integrin αvβ6. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting αvβ6.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.